OM
OMID Holdings, Inc.
OMID · OTC
$0.02 +0.00% (+$0.00)
1M -22.35%
Market Cap $2.25M
P/E Ratio -
Div. Yield -
ROE 70.10%
Piotroski F-Score Moderate
5/9Valuation
14 /100
Expensive P/B 28.17x
P/S 5.72x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 37.00%
Rev. growth 36.67%
FCF growth N/A
Profitability
0 /100
Weak Net margin 45.15%
Op. margin 80.21%
FCF margin 33.03%
Quality
12 /100
Poor ROE 70.10%
ROA 42.53%
Asset turnover 0.94x
Debt
23 /100
High Current ratio 28.80x
Int. coverage -104.11x
Debt/Equity 4.05x
Stability
2 /100
Unstable Rev. volatility 68.85%
EPS volatility 1,383.23%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na OMID
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Adam Frank
Employees
6
Headquarters
Phillipsburg
Nadcházející události
13 ŘÍJ
Earnings
Upcoming earnings report